Missouri Attorney General Catherine Hanaway filed a federal lawsuit Thursday challenging the Food and Drug Administration’s approval of a new generic version of the abortion drug mifepristone.
Hanaway is arguing that the decision endangers women by allowing unchecked mail-order distribution without basic medical safeguards.
The suit, joined by Kansas and Idaho, seeks to block the September 30 approval of the generic product from Evita Solutions and restore pre-2016 safety standards for the drug, including requirements for in-person medical evaluations to detect life-threatening conditions like ectopic pregnancies. ---More...